Rates of biologic drug survival and suspension by remission were both higher in those who initiated biologic treatment at <16 years.
Rituximab may be an effective treatment option for many patients with juvenile idiopathic arthritis who did not respond to other therapies.
Researchers sought to quantify the annual incidence of new-onset uveitis following JIA diagnosis and identify associated risk factors.
Psychological Flexibility Improves Resilience in Children With Juvenile Idiopathic Arthritis and Their Parents
Psychological flexibility in children with juvenile idiopathic arthritis and in their parents may represent resilience factors for dealing with pain and disability associated with the condition.
Researchers evaluated the long-term efficacy and safety of canakinumab in patients with active systemic juvenile idiopathic arthritis.
The approval was based on data from a randomized, double-masked, placebo-controlled study of 90 pediatric patients aged 2 to < 18 years with active JIA-associated non-infectious uveitis.
Researchers conducted a multicenter prospective study to identify clinical features characteristic of localized scleroderma in children.
For a more precise assessment of disease activity and treatment effectiveness in individuals with JIA, inclusion of MCP joints should be considered in the scoring system.
Over a 5-year period, the drug was well tolerated and associated with significant declines in urinary protein-creatinine ratio and mean prednisolone dose.
Female gender, older age, and higher patient activation scores predicted transition readiness in adolescent patients with arthritis.
Rheumatology Advisor Articles
- 5-Step Guide to Activity Tracker Use for Patients With Rheumatic Diseases
- Gout Associated With Worse Outcomes in Obstructive Coronary Artery Disease
- Filgotinib Effective for Treatment of Active Psoriatic Arthritis
- Standard Set of Outcomes Developed for Value-Based Health Care in Inflammatory Arthritis
- Clinically Meaningful Improvement in Rheumatoid Arthritis Assessed With RAPID-3
- Circadian Rhythm in Rheumatoid Arthritis: Using Chronotherapy to Improve Outcomes
- Transcutaneous Electrical Nerve Stimulation Reduces Pain, Fatigue in Fibromyalgia
- Aspirin, Anticoagulants Similarly Prevent VTE After TKA
- Study: Cold Weather Joint Pain and Other Weather-Related Pain
- Increased Opioid Prescribing Linked to Chronic Usage in Patients With RA
- Treatment Retention Rates Lower in Patients Switching From Originator to Biosimilar Etanercept
- Climate Change Expected to Lead to Rise in Lyme Disease
- Red Cell Distribution Width Linked to Cardiovascular Disease Risk Factors in Spondyloarthritis
- Higher Biologic Drug Survival in JIA With Younger Age at Treatment Initiation
- Enough Is Enough? When Health Metrics Shift From Useful to Too Much